Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cindy L. Evans
Observed names:
C Evans,
C L Evans,
C.L. Evans,
CINDY L. EVANS,
Cindy Evans,
Cindy L Evans
show all 6
Institution:
LabCorp (United States)
Observed institutions:
Harvard University,
Johns Hopkins University,
Universität Innsbruck,
Washington University in St. Louis,
LabCorp (United States),
Johns Hopkins Hospital,
Beckman Coulter (United States)
show all 7
OpenAlex ID:
A5007595678
A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer.
2001
·
S D Mikolajczyk
, K M Marker
, et al.
·
PubMed
·
191
Serum Pro Prostate Specific Antigen Improves Cancer Detection Compared to Free and Complexed Prostate Specific Antigen in Men With Prostate Specific Antigen 2 to 4 Ng/Ml
2003
·
WILLIAM J. CATALONA
, GEORG BARTSCH
, et al.
·
The Journal of Urology
·
168
Serum Pro-prostate Specific Antigen Preferentially Detects Aggressive Prostate Cancers in Men With 2 to 4 Ng/ml Prostate Specific Antigen
2004
·
WILLIAM J. CATALONA
, GEORG BARTSCH
, et al.
·
The Journal of Urology
·
160
Proenzyme Forms of Prostate-Specific Antigen in Serum Improve the Detection of Prostate Cancer
2004
·
Stephen D Mikolajczyk
, William J Catalona
, et al.
·
Clinical Chemistry
·
153
Proenzyme psa for the early detection of prostate cancer in the 2.5–4.0 ng/ml total psa range: preliminary analysis
2003
·
Lori J Sokoll
, Daniel W Chan
, et al.
·
Urology
·
121
Development of Monoclonal Antibodies Specific for Human Glandular Kallikrein (hK2): Development of a Dual Antibody Immunoassay for hK2 with Negligible Prostate-Specific Antigen Cross-reactivity
1998
·
Judith A Finlay
, Cindy L Evans
, et al.
·
Urology
·
59
Clinical utility of proPSA and “benign” PSA when percent free PSA is less than 15%
2004
·
Masood A. Khan
, Lori J. Sokoll
, et al.
·
Urology
·
53
Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer
1997
·
Jürgen Pannek
, Harry G. Rittenhouse
, et al.
·
Urology
·
41
Development and Advanced Validation of an Optimized Method for the Quantitation of Aβ42 in Human Cerebrospinal Fluid
2012
·
Valerie C. Cullen
, Ross A. Fredenburg
, et al.
·
The AAPS Journal
·
39
PDF
Development of a Dual Monoclonal Antibody Immunoassay for Total Human Kallikrein 2
2001
·
Judith A Finlay
, John R Day
, et al.
·
Clinical Chemistry
·
21
Calculations for Adjusting Endogenous Biomarker Levels During Analytical Recovery Assessments for Ligand-Binding Assay Bioanalytical Method Validation
2015
·
John F. Marcelletti
, Cindy L. Evans
, et al.
·
The AAPS Journal
·
13
PDF
Large-Scale Propagation of Recombinant Adherent Cells That Secrete a Stable Form of Human Glandular Kallikrein, hK2
1999
·
Abhay Kumar
, Amita S. Goel
, et al.
·
Protein Expression and Purification
·
9
EtNBS-based photodynamic therapy for the treatment of hypoxic and otherwise therapeutically unresponsive cancer cell populations
2011
·
Y.J. Park
, O.J. Klein
, et al.
·
Photodiagnosis and Photodynamic Therapy
Prototype reagents for an automated serum inducible nitric oxide synthase assay
2005
·
S Roberts
, D Binger
, et al.
·
Critical Care
PDF
1658: Effects of Prostate Biopsy on PSA Isoforms in men With BPH and Cancer
2004
·
Leonard S. Marks
, Stephen D. Mikolajczyk
, et al.
·
The Journal of Urology
Show more works
View as search
Works count:
15
Citation count:
1,028
H-index:
11
I10-index:
11
Year
Topic
Type
